Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Prelude Therapeutics (PRLD) Q1 2023 Earnings
PRLD
8
May
Confirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.68
-0.65
-0.61
-0.58
Details
Expected EPS
-0.68
Actual EPS
-0.58
Surprise EPS
0.1
Surprise Percent
+14.71%
Description
Prelude Therapeutics (PRLD) has reported earnings of -0.58 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login